Post

Medis, Axantis, Source Orphan Drugs from India’s Lupin

Medis, Axantis, Source Orphan Drugs from India’s Lupin

Mumbai-based global pharma major Lupin, signed a distribution agreement with Slovenia-based Medis for Lupin’s orphan drug NaMuscla® (mexiletine).

Medis will commercialize NaMuscla® for the symptomatic treatment of myotonia in adults with non-dystrophic myotonic (NDM) disorders in Central and Eastern European countries, namely Croatia, Czech Republic, Hungary, Slovakia, and Slovenia in the first phase. Lupin will commercialize the drug in Germany, France, and the U.K.

NDM disorders are a group of rare, inherited neuromuscular disorders characterized by the inability to relax muscles following voluntary contraction. NaMuscla® is the first and only licensed product for NDM designated orphan drug status. It received EU marketing authorization in December 2018.

In other news, Lupin and Axantia, holding company of Pharma International – Jordan, and Med City Pharma – Saudi Arabia, entered into a License, Supply and Technology Sharing Agreement for Pegfilgrastim in the Middle East and North Africa.

Axantia will register, distribute, and market biosimilar Pegfilgrastim in certain territories including Saudi Arabia, certain GCC countries, Jordan, Lebanon, Iraq, Sudan, Libya and Algeria.

Pegfilgrastim is indicated to reduce the duration of neutropenia and the incidence of febrile neutropenia in patients receiving chemotherapy.

Share

About Amritt

Who We Are

Small or big, your business will love our financial help and business consultations! We are happy when our clients are too… Actually, this is quite simple to achieve – because each time we help them in sorting out different accounting intricacies or save the day before filing the taxes, they are happy indeed! And so are we.   

We have over Twenty years of experience helping our clients succeed in India

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Blog
Page
Dictionary
Comparisons
Capabilities
India Business Guide
Services
Private
Speaking
Insights
White Papers
News
Newsletters
Clients
Case Studies
Companies In India
Webinars
Presentations
Industries